Old Web
English
Sign In
Acemap
>
authorDetail
>
Pawat Pattarawat
Pawat Pattarawat
University of Tennessee
Romidepsin
Cisplatin
Gemcitabine
Cancer research
Histone deacetylase inhibitor
4
Papers
12
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
A triple combination gemcitabine + romidepsin + cisplatin to effectively control triple-negative breast cancer tumor development, recurrence, and metastasis
2021
Cancer Chemotherapy and Pharmacology
Pawat Pattarawat
Jessica T. Hunt
Jacob Poloway
Collin J. Archibald
Hwa-Chain Robert Wang
Show All
Source
Cite
Save
Citations (0)
Compensatory combination of romidepsin with gemcitabine and cisplatin to effectively and safely control urothelial carcinoma.
2020
British Journal of Cancer
Pawat Pattarawat
Tian Hong
Shelby Wallace
Yanchun Hu
Robert L. Donnell
Tzu-Hao Wang
Chia-Lung Tsai
Jinquan Wang
Hwa-Chain Robert Wang
Show All
Source
Cite
Save
Citations (4)
Formulation of a triple combination gemcitabine plus romidepsin + cisplatin regimen to efficaciously and safely control triple-negative breast cancer tumor development
2019
Cancer Chemotherapy and Pharmacology
Pawat Pattarawat
Shelby Wallace
Bianca Pfisterer
Agricola Odoi
Hwa-Chain Robert Wang
Show All
Source
Cite
Save
Citations (8)
Abstract C038: Targeting aberrant pathways by an advanced combination regimen to effectively and safely control urothelial carcinoma
2019
Molecular Cancer Therapeutics
Hwa-Chain Wang
Pawat Pattarawat
Shelby Wallace
Robert L. Donnell
Show All
Source
Cite
Save
Citations (0)
1